SELLAS Life Sciences SLS
NASDAQ SLS
$12.14 +0.16 (+1.34%)
At close: Oct 21, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Change in Receivables (2013 - 2022)

Updated

SELLAS Life Sciences' Change in Receivables came in at $1 million for Q1 2022.

Analysis

SELLAS Life Sciences (SLS) Change in Receivables (2013 - 2022) Analysis & Trends

For FY2014, SELLAS Life Sciences' Change in Receivables was -$1.64 million.

  • Going back by year, Change in Receivables was $3.68 million in FY2013.
  • The Q1 2022 figure represents the highest quarterly Change in Receivables since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 SELLAS Life Sciences 2.30 Bn 1.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.00 Mn
Jun 30, 2015 758,000.00
Mar 31, 2015 -779,000.00
Dec 31, 2014 604,000.00
Sep 30, 2014 -717,000.00
Jun 30, 2014 686,000.00
Mar 31, 2014 -2.22 Mn
Dec 31, 2013 2.14 Mn
Sep 30, 2013 1.54 Mn
API Access

SELLAS Life Sciences Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SLS&period=max&api_key=YOUR_API_KEY